Capillary Malformation
No Results
No Results
processing….
Capillary malformation, usually referred to as a port-wine stain or nevus flammeus, is the most common type of vascular malformation. As a congenital malformation of the superficial dermal blood vessels, capillary malformation is present at birth and grows in size commensurate with the child; capillary malformations remain present for life and have no tendency toward involution. A rare form of capillary malformation that is not present at birth is referred to as an acquired capillary malformation; however, this article focuses on the more common congenital lesion.
Past nosology of this lesion has resulted in much confusion, and an excessive number of descriptive terms have been applied to it. Confusion originated from difficulty in differentiating vascular malformations from vascular proliferative lesions, such as hemangiomas, and from the use of wholly clinical descriptions in categorizing these lesions. According to the International Society for the Study of Vascular Anomalies (ISSVA) classification, vascular malformations are classified according to their predominant vessel type, such as arterial, venous, lymphatic, capillary, or complex (a combination of different vessels). [1]
Although some capillary malformations may be associated with other vessel malformations, most occur alone as venulocapillary malformations. Happle contends that the term capillary malformation should be used as a more generalized designation for several congenital disorders of dilated capillaries (eg, angiokeratomas, nevus anemicus, cutis marmorata telangiectatica congenita). [2] While this notion has merit, the accepted nomenclature is that capillary malformation be reserved for a patch of red-colored skin, historically referred to as a port-wine stain or a nevus flammeus.
Capillary malformations and other vascular malformations are the result of abnormal morphogenesis. Capillary malformations are characterized by ectatic papillary dermal capillaries and postcapillary venules in the upper reticular dermis, with some evidence of increased vessel density and no apparent proliferation of vessels. These ectatic vessels are lined by flat, benign-appearing endothelial cells, similar to the vessels of normal skin, with similar staining characteristics for endothelial antigens, including fibronectin, von Willebrand factor, and collagenous basement membrane proteins. The endothelial cells also exhibit cell turnover similar to normal vessels, supported by a paucity of mitoses or an uptake of tritiated thymidine. One study demonstrated a mean vessel depth of 0.46 mm in capillary malformations, suggesting that most of the vessels are superficial.
Evidence supports a neural role in both the development and progression of capillary malformations. Animal studies show that the sympathetic nervous system influences the composition and functional properties of the vessel wall during development.
Immunohistochemical studies of capillary malformations reveal a significantly decreased density of perivascular nervous tissue in lesional skin, suggesting that inadequate innervation may be in part responsible for decreased vascular tone and progressive vascular dilatation. [3] Confocal microscopic studies demonstrate an inverse correlation between nerve density and blood vessel diameter and evidence that capillary malformations with the lowest nerve density exhibit the highest blood vessel density and the poorest response to laser intervention. [4] The finding of increased vessel diameter and/or decreased nerve density may be secondary to other factors, such as local cytokine production or abnormal receptors; however, this has not been elucidated.
The potent endothelial cell mitogen vascular endothelial growth factor (VEGF)–A and its most active receptor VEGF-R2 expression are significantly increased in capillary malformation skin tissue compared with control skin. [5] This may suggest that VEGF and VEGF-R could contribute to the pathogenesis of capillary malformations by inducing vessel proliferation and/or vasodilatation. If this is indeed a pathogenic factor, antiangiogenic treatments using VEGF blocking agents may prove to be useful for capillary malformations. Conversely, one report describes expansion of a biopsy-proven capillary malformation following partial surgical excision in an adult in whom the newly expanded capillary malformation expressed marked elevations of both tyrosine kinase receptor (Tie2) and its ligand angiopoietin-1 and no increase in VEGF. [6] Tie2 and angiopoietin-1 are known regulators of vascular remodeling during angiogenesis, mutations of which have been demonstrated in familial venous malformations.
A somatic activating mutation encoding a p.Arg183Gln amino acid substitution in GNAQ, a q class of G-protein alpha subunits that mediates signals between G-protein–coupled receptors and their downstream effectors, has been shown to be the etiology of capillary malformations. [7] This specific mutation was found in both lesional skin of nonsyndromic capillary malformations and in the lesional skin and affected brain tissue of patients with Sturge-Weber syndrome (SWS). Additionally, the endothelial cells of capillary malformations possess a higher density of the GNAQ mutation than other cells in the affected tissue. [8] Other mutations in this G-protein have been identified in blue nevi, nevus of Ota, and in uveal melanoma. This helps explain the occurrence of both melanocytic nevi and capillary malformations co-localizing to the same area in phakomatosis pigmentovascularis. This G protein is in the MAP/MEK cell proliferation pathway. It has been posited that the timing of the mutation explains the tissue involvement and severity of the condition, with an earlier mutation occurring in SWS and a later one in nonsyndromic capillary malformations.
An inactivating mutation of RASA1 on 5q has been detected in some kindreds with multiple, small, round-to-oval, pink capillary malformations. [9] RASA1 encodes a GTPase-activating protein, which negatively regulates Ras activity. These kindreds all had members who also had arteriovenous malformations (AVMs) or arteriovenous fistulae (AVFs). This disease has been coined capillary malformation-AVM syndrome to denote the 2 types of vascular malformations observed in these kindreds. One kindred with a novel RASA1 -inactivating mutation included a member with a large lower extremity capillary malformation with associated ipsilateral limb enlargement [10] ; however, another large kindred has been identified that has only capillary malformations and no evidence of AVMs or AVFs, suggesting that RASA1 mutations may be implicated more often than previously believed. [11]
Use of transcutaneous videomicroscopy and handheld dermoscopy reveals two distinct patterns of vascular ectasia in capillary malformations. The type 1 abnormality is composed of superficial, tortuous, dilated end-capillary loops in the superficial papillary dermis. The type 2 abnormality consists of dilated, ectatic vessels in the superficial horizontal vascular plexus. Some patients exhibit a combination of both abnormal patterns. Evidence suggests that the type 1 abnormality has a better response to 585-nm flashlamp-pumped pulsed-dye laser (PDL) therapy than the type 2 abnormality. [12] Moreover, one study found a correlation between the depth and pattern of the capillary malformations and the location of the lesions, demonstrating improved responses to laser therapy with locations demonstrating a type 1 pattern (V3 region of the face, neck, and trunk).
United States
Capillary malformation occurs in 0.3-0.5% of newborns.
International
Worldwide, capillary malformation occurs in 0.1-2% of newborns.
According to at least one survey, capillary malformations are more common in whites than in African Americans. [13]
The sex distribution of capillary malformations is equal.
Capillary malformations are present at birth. Some lesions may not be readily observed at birth because of anemia or plethora. In certain lesions, some lightening of the lesions may occur during the first year of life; however, beyond that time, further lightening is generally not observed.
The very rare acquired port-wine stain can occur at any age after birth and is identical to congenital capillary malformations both clinically and histologically. The etiology of these lesions is unknown and most are idiopathic; however, trauma, chronic UV exposure, hormonal influences, infections, solid brain tumor, and various internal vascular disorders have been implicated. [14]
Isolated capillary malformations do not appear to cause an increase in mortality; however, psychosocial disability secondary to facial disfigurement can be overwhelming. Several studies demonstrate that patients with facial capillary malformations exhibit greater self-concern, ruminative self-doubt in interpersonal interactions, social inhibition, isolated and passive orientation in interpersonal relationships, stigmatization from society, and limitations of privileges and opportunities otherwise afforded to those without facial disfigurement. One study demonstrated that the psychosocial difficulties not only persisted but actually worsened in adulthood. [15]
Development of lobulated capillary hemangiomas (pyogenic granulomas) within capillary malformations often results in bleeding. [16, 17] The destruction of these lesions usually results in minor scarring of the skin.
Any morbidity involved with capillary malformations is associated with more extensive vascular malformations.
Patients and parents benefit from an organized, informative, multidisciplinary effort to address psychological, medical, and surgical needs for optimal outcomes from medical care, especially surgical or laser procedures.
In the author’s experience, a frank discussion with the affected child’s classmates early in the school year is most beneficial. A brief classroom discussion, which can be facilitated by the patient’s parent or teacher, offers an opportunity to educate the child’s classmates about the birthmark and to reassure them that it is neither painful nor contagious. Once the capillary malformation has been explained adequately and questions answered, most children cease to further question the child. This helps to alleviate some of the patient’s psychological burden.
Buddy Booby’s Birthmark, by Evan Ducker, a child with a capillary malformation, and his mother, Donna Cardenia Ducker, is a children’s picture book depicting a baby booby bird on the Galapagos Islands that was born with a capillary malformation (birthmark) on his beak. It is the first children’s book of its kind to depict the social stressors associated with facial capillary malformations. It is available for purchase at http://www.amazon.com/Buddy-Boobys-Birthmark-Donna-Ducker/dp/0979441315.
Wassef M, Blei F, Adams D, Alomari A, Baselga E, Berenstein A, et al. Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies. Pediatrics. 2015 Jul. 136 (1):e203-14. [Medline].
Happle R. Capillary malformations: a classification using specific names for specific skin disorders. J Eur Acad Dermatol Venereol. 2015 Dec. 29 (12):2295-305. [Medline].
Smoller BR, Rosen S. Port-wine stains. A disease of altered neural modulation of blood vessels?. Arch Dermatol. 1986 Feb. 122(2):177-9. [Medline].
Chang CJ, Yu JS, Nelson JS. Confocal microscopy study of neurovascular distribution in facial port wine stains (capillary malformation). J Formos Med Assoc. 2008 Jul. 107(7):559-66. [Medline].
Vural E, Ramakrishnan J, Cetin N, Buckmiller L, Suen JY, Fan CY. The expression of vascular endothelial growth factor and its receptors in port-wine stains. Otolaryngol Head Neck Surg. 2008 Oct. 139(4):560-4. [Medline].
Kaji N, Nagase T, Nagase M, Koshima I. Changes in angiogenic gene expression in a case of expanded capillary malformation: does an expanded capillary malformation grow?. Ann Plast Surg. 2005 Jun. 54(6):645-50. [Medline].
Shirley MD, Tang H, Gallione CJ, Baugher JD, Frelin LP, Cohen B. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med. 2013 May 23. 368(21):1971-9. [Medline].
Couto JA, Huang L, Vivero MP, Kamitaki N, Maclellan RA, Mulliken JB, et al. Endothelial Cells from Capillary Malformations Are Enriched for Somatic GNAQ Mutations. Plast Reconstr Surg. 2016 Jan. 137 (1):77e-82e. [Medline].
Boon LM, Mulliken JB, Vikkula M. RASA1: variable phenotype with capillary and arteriovenous malformations. Curr Opin Genet Dev. 2005 Jun. 15(3):265-9. [Medline].
Hershkovitz D, Bergman R, Sprecher E. A novel mutation in RASA1 causes capillary malformation and limb enlargement. Arch Dermatol Res. 2008 Aug. 300(7):385-8. [Medline].
Hershkovitz D, Bercovich D, Sprecher E, Lapidot M. RASA1 mutations may cause hereditary capillary malformations without arteriovenous malformations. Br J Dermatol. 2008 May. 158(5):1035-40. [Medline].
Motley RJ, Lanigan SW, Katugampola GA. Videomicroscopy predicts outcome in treatment of port-wine stains. Arch Dermatol. 1997 Jul. 133(7):921-2. [Medline].
Pratt AG. Birthmarks in infants. AMA Arch Derm Syphilol. 1953 Mar. 67(3):302-5. [Medline].
Afsar FS, Ortac R. Acquired port-wine stain in a pediatric patient. J Cutan Med Surg. 2006 May-Jun. 10(3):151-3. [Medline].
Lanigan SW, Cotterill JA. Psychological disabilities amongst patients with port wine stains. Br J Dermatol. 1989 Aug. 121(2):209-15. [Medline].
Sheehan DJ, Lesher JL Jr. Pyogenic granuloma arising within a port-wine stain. Cutis. 2004 Mar. 73(3):175-80. [Medline].
da Silva AD, Silva CA, de Camargo Moraes P, Thomaz LA, Furuse C, de Araújo VC. Recurrent oral pyogenic granuloma in port-wine stain. J Craniofac Surg. 2011 Nov. 22(6):2356-8. [Medline].
Geronemus RG, Ashinoff R. The medical necessity of evaluation and treatment of port-wine stains. J Dermatol Surg Oncol. 1991 Jan. 17(1):76-9. [Medline].
Maari C, Frieden IJ. Klippel-Trénaunay syndrome: the importance of “geographic stains” in identifying lymphatic disease and risk of complications. J Am Acad Dermatol. 2004 Sep. 51(3):391-8. [Medline].
Ch’ng S, Tan ST. Facial port-wine stains – clinical stratification and risks of neuro-ocular involvement. J Plast Reconstr Aesthet Surg. 2008 Aug. 61(8):889-93. [Medline].
Pascual-Castroviejo I, Pascual-Pascual SI, Velazquez-Fragua R, Viano J. Sturge-Weber syndrome: study of 55 patients. Can J Neurol Sci. 2008 Jul. 35(3):301-7. [Medline].
Huiras EE, Barnes CJ, Eichenfield LF, Pelech AN, Drolet BA. Pulmonary thromboembolism associated with Klippel-Trenaunay syndrome. Pediatrics. 2005 Oct. 116(4):e596-600. [Medline].
Samimi M, Maruani A, Bertrand P, Arbeille P, Lorette G. Arterial blood flow in limbs with port-wine stains can predict length discrepancy. Br J Dermatol. 2009 Jan. 160(1):219-20. [Medline].
Lee MS, Liang MG, Mulliken JB. Diffuse capillary malformation with overgrowth: a clinical subtype of vascular anomalies with hypertrophy. J Am Acad Dermatol. 2013 Oct. 69(4):589-94. [Medline].
Larralde M, Abad ME, Luna PC, Hoffner MV. Capillary malformation-arteriovenous malformation: a clinical review of 45 patients. Int J Dermatol. 2014 Apr. 53 (4):458-61. [Medline].
Martín-Santiago A, Knöpfel N, del Pozo J, Escalas J, Bartolomé B, Janer V, et al. Hypotrichosis associated with capillary malformation-arteriovenous malformation syndrome. Br J Dermatol. 2015 Feb. 172 (2):450-4. [Medline].
Keppler-Noreuil KM, Rios JJ, Parker VE, Semple RK, Lindhurst MJ, Sapp JC, et al. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A. 2015 Feb. 167A (2):287-95. [Medline].
Toriello HV, Mulliken JB. Accurately renaming macrocephaly-cutis marmorata telangiectatica congenita (M-CMTC) as macrocephaly-capillary malformation (M-CM). Am J Med Genet A. 2007 Dec 15. 143A(24):3009. [Medline].
Kuint J, Globus O, Ben Simon GJ, Greenberger S. Macrocephaly-capillary malformation presenting with fetal arrhythmia. Pediatr Dermatol. 2012 May-Jun. 29(3):384-6. [Medline].
Faqeih EA, Bastaki L, Rosti RO, Spencer EG, Zada AP, Saleh MA, et al. Novel STAMBP mutation and additional findings in an Arabic family. Am J Med Genet A. 2015 Apr. 167A (4):805-9. [Medline].
Guggisberg D, Hadj-Rabia S, Viney C, et al. Skin markers of occult spinal dysraphism in children: a review of 54 cases. Arch Dermatol. 2004 Sep. 140(9):1109-15. [Medline].
Tubbs RS, Wellons JC 3rd, Iskandar BJ, Oakes WJ. Isolated flat capillary midline lumbosacral hemangiomas as indicators of occult spinal dysraphism. J Neurosurg. 2004 Feb. 100(2 Suppl Pediatrics):86-9. [Medline].
Happle R. Phacomatosis pigmentovascularis revisited and reclassified. Arch Dermatol. 2005 Mar. 141(3):385-8. [Medline].
Lapidoth M, Ben Amitai D, Feinmesser M, Akerman L. Capillary malformation associated with angiolipoma: analysis of 127 consecutive clinic patients. Am J Clin Dermatol. 2008. 9(6):389-92. [Medline].
Happle R. Loss of heterozygosity in human skin. J Am Acad Dermatol. 1999 Aug. 41(2 Pt 1):143-64. [Medline].
Fonder MA, Mamelak AJ, Kazin RA, Cohen BA. Port-wine-stain-associated dermatitis: implications for cutaneous vascular laser therapy. Pediatr Dermatol. 2007 Jul-Aug. 24(4):376-9. [Medline].
Kouba DJ, Yip D, Fincher EF, Moy RL. Topical imiquimod in the treatment of a long-standing capillary malformation. Br J Dermatol. 2007 Nov. 157(5):1071-2. [Medline].
Tremaine AM, Armstrong J, Huang YC, Elkeeb L, Ortiz A, Harris R, et al. Enhanced port-wine stain lightening achieved with combined treatment of selective photothermolysis and imiquimod. J Am Acad Dermatol. 2012 Apr. 66(4):634-41. [Medline]. [Full Text].
Faurschou A, Olesen AB, Leonardi-Bee J, Haedersdal M. Lasers or light sources for treating port-wine stains. Cochrane Database Syst Rev. 2011 Nov 9. 11:CD007152. [Medline].
Goldman MP, Fitzpatrick RE. Laser treatment of cutaneous vascular lesions. Goldman MP, Fitzpatrick RE, eds. Cutaneous Laser Surgery: The Art and Science of Selective Photothermolysis. 2nd ed. Mosby-Year Book: St. Louis, Mo; 1999. 37-74.
Sivarajan V, Maclaren WM, Mackay IR. The effect of varying pulse duration, wavelength, spot size, and fluence on the response of previously treated capillary vascular malformations to pulsed-dye laser treatment. Ann Plast Surg. 2006 Jul. 57(1):25-32. [Medline].
Kono T, Groff WF, Sakurai H. Treatment of port wine stains with the pulse dye laser. Ann Plast Surg. 2006 Apr. 56(4):460-3. [Medline].
Swan BC, Robertson SJ, Tuxen A, Ma E, Yip L, Ly L, et al. Pulsed dye laser treatment of capillary malformations in infants at 2-weekly versus 3-monthly intervals, reducing the need for general anaesthesia. Australas J Dermatol. 2016 Feb 23. [Medline].
Sivarajan V, MacKay IR. The relationship between location, color, and vessel structure within capillary vascular malformations. Ann Plast Surg. 2004 Oct. 53(4):378-81. [Medline].
Jia W, Aguilar G, Verkruysse W, Franco W, Nelson JS. Improvement of port wine stain laser therapy by skin preheating prior to cryogen spray cooling: a numerical simulation. Lasers Surg Med. 2006 Feb. 38(2):155-62. [Medline].
Phung TL, Oble DA, Jia W, Benjamin LE, Mihm MC Jr, Nelson JS. Can the wound healing response of human skin be modulated after laser treatment and the effects of exposure extended? Implications on the combined use of the pulsed dye laser and a topical angiogenesis inhibitor for treatment of port wine stain birthmarks. Lasers Surg Med. 2008 Jan. 40(1):1-5. [Medline].
Chang CJ, Hsiao YC, Mihm MC Jr, Nelson JS. Pilot study examining the combined use of pulsed dye laser and topical Imiquimod versus laser alone for treatment of port wine stain birthmarks. Lasers Surg Med. 2008 Nov. 40(9):605-10. [Medline]. [Full Text].
Gu Y, Huang NY, Liang J, Pan YM, Liu FG. [Clinical study of 1949 cases of port wine stains treated with vascular photodynamic therapy (Gu’s PDT)]. Ann Dermatol Venereol. 2007 Mar. 134(3 Pt 1):241-4. [Medline].
Huikeshoven M, Koster PH, de Borgie CA, Beek JF, van Gemert MJ, van der Horst CM. Redarkening of port-wine stains 10 years after pulsed-dye-laser treatment. N Engl J Med. 2007 Mar 22. 356(12):1235-40. [Medline].
Huikeshoven M, Koster PH, de Borgie CA, Beek JF, van Gemert MJ, van der Horst CM. Redarkening of port-wine stains 10 years after pulsed-dye-laser treatment. N Engl J Med. 2007 Mar 22. 356(12):1235-40. [Medline].
Ozdemir M, Engin B, Mevlitoglu I. Treatment of facial port-wine stains with intense pulsed light: a prospective study. J Cosmet Dermatol. 2008 Jun. 7(2):127-31. [Medline].
Tierney EP, Hanke CW. Alexandrite laser for the treatment of port wine stains refractory to pulsed dye laser. Dermatol Surg. 2011 Sep. 37(9):1268-78. [Medline].
Yang MU, Yaroslavsky AN, Farinelli WA, et al. Long-pulsed neodymium:yttrium-aluminum-garnet laser treatment for port-wine stains. J Am Acad Dermatol. 2005 Mar. 52(3 Pt 1):480-90. [Medline].
Pence B, Aybey B, Ergenekon G. Outcomes of 532 nm frequency-doubled Nd:YAG laser use in the treatment of port-wine stains. Dermatol Surg. 2005 May. 31(5):509-17. [Medline].
Huang YC, Ringold TL, Nelson JS, Choi B. Noninvasive blood flow imaging for real-time feedback during laser therapy of port wine stain birthmarks. Lasers Surg Med. 2008 Mar. 40(3):167-73. [Medline]. [Full Text].
Kolkman RG, Mulder MJ, Glade CP, Steenbergen W, van Leeuwen TG. Photoacoustic imaging of port-wine stains. Lasers Surg Med. 2008 Mar. 40(3):178-82. [Medline].
Richard J Antaya, MD Director of Pediatric Dermatology, Professor, Departments of Dermatology and Pediatrics, Yale University School of Medicine
Richard J Antaya, MD is a member of the following medical societies: American Academy of Dermatology, American Academy of Pediatrics, Society for Pediatric Dermatology
Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Pierre-Fabre Pharmaceuticals.
Richard P Vinson, MD Assistant Clinical Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine; Consulting Staff, Mountain View Dermatology, PA
Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Texas Medical Association, Association of Military Dermatologists, Texas Dermatological Society
Disclosure: Nothing to disclose.
Van Perry, MD Assistant Professor, Department of Medicine, Division of Dermatology, University of Texas School of Medicine at San Antonio
Van Perry, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.
Dirk M Elston, MD Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.
Mark W Cobb, MD Consulting Staff, WNC Dermatological Associates
Mark W Cobb, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Society of Dermatopathology
Disclosure: Nothing to disclose.
Capillary Malformation
Research & References of Capillary Malformation|A&C Accounting And Tax Services
Source
0 Comments